BusinessExosome Diagnostics Announces National Medicare Reimbursement Rate Set at $760 for its Prostate Cancer IntelliScore TestBy Nasdaq OMXNov 27, 2017, 1:16 PM UTC
BusinessTESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian CancerBy Nasdaq OMXNov 20, 2017, 12:01 PM UTC
BusinessDeciphera Pharmaceuticals Reports Data from Ongoing Phase 1 Clinical Study of DCC-2618 at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-OncologyBy Nasdaq OMXNov 20, 2017, 12:00 PM UTC
BusinessVeritas’ Research Arm Cannevert Therapeutics Signs Letter of Intent with Fundación de Investigación (FDI) of Puerto Rico USA to Begin Human Trials of Its Lead Cannabis Strain for PainBy Nasdaq OMXNov 20, 2017, 8:05 AM UTC
BusinessKarmanos Cancer Institute presents its 2017 Heroes of CancerBy Nasdaq OMXNov 16, 2017, 10:52 PM UTC
BusinessALGAE DYNAMICS CORP ANNOUNCES C$400,000 RESEARCH GRANT FROM MITACS TO SUPPORT CANNABIS RESEARCH WITH UNIVERSITY OF WESTERN ONTARIOBy Nasdaq OMXNov 16, 2017, 2:01 PM UTC
BusinessAmerican Health Council Recognizes Todd Heaton, MD, MPH as “America’s Best Doctor”By Nasdaq OMXNov 15, 2017, 3:35 PM UTC
